After exposure to herpes simplex virus type 2 (HSV‑2), what is the earliest time that IgM and IgG antibodies can be detected on a blood test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

HSV-2 Antibody Detection Timeline After Exposure

Wait 12 weeks (3 months) after possible HSV-2 exposure before testing for IgG antibodies to reliably detect or exclude infection. 1

Understanding the Window Period

The serologic window period for HSV-2 antibody detection can extend up to 12 weeks after initial exposure 1. This means:

  • False-negative results are common if tested too early during this window period
  • Testing before 12 weeks may miss recent infections entirely
  • The sensitivity of HSV-2 IgG testing is approximately 92%, but this assumes testing occurs after the window period 1

IgM vs IgG: What You Need to Know

IgM Antibodies

  • IgM appears earlier but is unreliable for diagnosis
  • In primary HSV-2 infections, IgM may be detected in only 17% of sera within the first 10 days, increasing to 95% after 10 days 2
  • Research shows median detection time of approximately 13 days for early antibody response 3
  • Critical pitfall: IgM can persist in 29-33% of people with established chronic HSV-2 infection 4, making it useless for distinguishing new from old infection
  • IgM testing detected recent infection in only 63% of early HSV-2 cases 4

IgG Antibodies (Preferred)

  • IgG is the standard for HSV-2 diagnosis, not IgM
  • Appears after the first week of infection but may take up to 12 weeks to become reliably detectable 1, 5
  • Do not repeat serologic testing until 12 weeks after exposure 1

Critical Testing Considerations

Test Performance Issues You Must Know

The commercially available HSV-2 IgG tests have significant limitations:

  • Low-positive results (index values 1.1-2.9) have only 39.8% specificity 1
  • Index values ≥3.0 improve specificity to 78.6% but false positives still occur even above 3.5 1
  • People with HSV-1 infection are more likely to have false-positive HSV-2 results at low index values 1

Recommended Testing Algorithm

  1. Wait the full 12 weeks after exposure before initial testing
  2. If positive with index value <3.0: Confirm with a second assay (Biokit HSV-2 rapid test or Western blot) 1
  3. If positive with index value ≥3.0: May be sufficient without confirmation, though false positives can still occur 1
  4. If negative at 12 weeks: HSV-2 infection is effectively ruled out

Common Pitfalls to Avoid

  • Do not order IgM testing - it adds little diagnostic value and causes confusion 4
  • Do not test before 12 weeks - you will get false negatives 1
  • Do not accept low-positive results without confirmation - specificity is only 39.8% for index values 1.1-2.9 1
  • Do not ignore HSV-1 status - HSV-1 positive patients have higher false-positive HSV-2 rates 1

If Testing Is Needed Earlier

If clinical suspicion exists before 12 weeks and lesions are present:

  • PCR or viral culture from lesions is preferred over serology 1
  • Serology can be added but negative results do not exclude recent infection
  • Repeat serology at 12 weeks if initial test is negative

Related Questions

What does a low HSV‑2 IgG level of 1.11 U/mL from Quest Diagnostics with an unmeasurable inhibition assay indicate when measured four weeks after a confirmed HSV‑2 exposure?
What does a herpes simplex virus type 2 (HSV‑2) IgG index of 9 indicate, and how should an asymptomatic patient be managed?
Is a 25–35 % probability of a borderline HSV‑2 IgG result considered a high chance of true early HSV‑2 infection?
What does a low HSV‑2 IgG of 1.11 (with non‑measurable inhibition) obtained four weeks after a confirmed HSV‑2 exposure indicate, given the patient also has a high HSV‑1 IgG (~9)?
Can Herpes Simplex Virus 2 (HSV 2) Immunoglobulin G (IgG) test results fluctuate from a high index to a low index?
How should unilateral mid‑back pain be evaluated and managed in a pregnant patient?
In an adult with chronic kidney disease or end‑stage renal disease and persistent hyperphosphatemia, which phosphate binder should be used and how should it be administered?
In interpreting an arterial blood gas, should I use the actual bicarbonate (HCO3‑act) or the standard bicarbonate (HCO3‑std)?
In a cancer patient who completed his second cycle of gemcitabine (Gemzar) and carboplatin on [date], is the onset of loose stools (diarrhea) on [date] a rational time frame for this regimen to cause diarrhea?
What are the selection criteria for endoscopic lung volume reduction?
In a pregnant patient with unilateral mid‑thoracic back pain, is ultrasound appropriate for evaluating the spine, or should MRI be used instead?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.